Drug Shortage Report for SHINGRIX

Last updated on 2020-06-18 History
Report ID 59145
Drug Identification Number 02468425
Brand name SHINGRIX
Common or Proper name Herpes Zoster vaccine
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
Strength(s) 50MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 10's
ATC code J07BK
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-08-24
Estimated end date
Actual end date 2020-06-17
Shortage status Resolved
Updated date 2020-06-18
Company comments High demand for the drug coupled with the variable timing of supply shipments. Re-supply is ongoing with current inventory on allocation.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2020-06-18 French Compare
v25 2020-06-18 English Compare
v24 2020-02-27 French Compare
v23 2020-02-27 English Compare
v22 2019-10-18 French Compare
v21 2019-10-18 English Compare
v20 2019-07-10 French Compare
v19 2019-07-10 English Compare
v18 2019-04-10 French Compare
v17 2019-04-10 English Compare
v16 2019-01-18 French Compare
v15 2019-01-18 English Compare
v14 2019-01-11 French Compare
v13 2019-01-11 English Compare
v12 2018-12-20 French Compare
v11 2018-12-20 English Compare
v10 2018-12-03 French Compare
v9 2018-12-03 English Compare
v8 2018-11-27 French Compare
v7 2018-11-27 English Compare

Showing 1 to 20 of 26